Relationship between Serum p-Tau Levels and Impaired Cognitive Function in Type 2 Diabetes Mellitus

Authors

  • Isnu Lucky Riandini Neurology Resident, Department of Neurology, Faculty of Medicine, Universitas Andalas, Padang, Indonesia
  • Yuliarni Syafrita Staff, Department of Neurology, Faculty of Medicine, Universitas Andalas, Padang, Indonesia
  • Restu Susanti Staff, Department of Neurology, Faculty of Medicine, Universitas Andalas, Padang, Indonesia
  • Syarif Indra Staff, Department of Neurology, Faculty of Medicine, Universitas Andalas, Padang, Indonesia
  • Lydia Susanti Staff, Department of Neurology, Faculty of Medicine, Universitas Andalas, Padang, Indonesia
  • Fanny Adhy Putri Staff, Department of Neurology, Faculty of Medicine, Universitas Andalas, Padang, Indonesia
  • Reno Bestari Staff, Department of Neurology, Faculty of Medicine, Universitas Andalas, Padang, Indonesia

DOI:

https://doi.org/10.37275/bsm.v8i8.1041

Keywords:

Cognitive function, Diabetes mellitus type 2, Phosphorylated Tau

Abstract

Background: Type 2 diabetes mellitus (Type 2 DM) is a metabolic disease that causes a global crisis that threatens health and the world economy. Impaired cognitive function is a key factor in reducing health-related quality of life in type 2 DM patients. Phosphorylated Tau (p-Tau) is a microtubule protein that functions in cell signaling, synaptic plasticity, and regulation of genome stability. A malfunction of p-Tau will cause disruption of cell signaling, which can result in impaired cognitive function. This study aims to assess the relationship between serum p-Tau levels and impaired cognitive function in type 2 diabetes mellitus patients.

Methods: This research is an observational study, comparative analysis with a cross-sectional design with a sample of 60 type 2 diabetes mellitus patients who sought treatment at the endocrine polyclinic at Dr. M. Djamil General Hospital Padang. Cognitive function was assessed using MoCa-Ina. Serum p-Tau levels were measured using the ELISA method. Data analysis was carried out using SPSS.

Results: The average serum p-Tau level in type 2 diabetes mellitus patients with impaired cognitive function was 542.9 pg/ml. The cut-off point for serum p-Tau levels which is associated with impaired cognitive function in type 2 diabetes mellitus patients is 517.2 pg/ml. There was a significant relationship between serum p-Tau levels and impaired cognitive function in type 2 diabetes mellitus patients (p=0.039).

Conclusion: There is a significant relationship between serum p-Tau levels and impaired cognitive function in type 2 diabetes mellitus patients.

Authors

  • Isnu Lucky Riandini1*
  • Yuliarni Syafrita2
  • Restu Susanti2
  • Syarif Indra2
  • Lydia Susanti2
  • Fanny Adhy Putri2
  • Reno Bestari2
  1. 1Neurology Resident, Department of Neurology, Faculty of Medicine, Universitas Andalas, Padang, Indonesia
  2. 2Staff, Department of Neurology, Faculty of Medicine, Universitas Andalas, Padang, Indonesia

Corresponding author Isnu Lucky Riandini — isnu_lucky@yahoo.com

Article history

  1. Submitted
  2. Accepted
  3. Published

Downloads

Published

2024-05-17

Article metrics

575Abstract views
344PDF downloads

How to Cite

1.
Riandini IL, Yuliarni Syafrita, Restu Susanti, Syarif Indra, Lydia Susanti, Fanny Adhy Putri, et al. Relationship between Serum p-Tau Levels and Impaired Cognitive Function in Type 2 Diabetes Mellitus. Bioscmed [Internet]. 2024 May 17 [cited 2026 Aug. 12];8(8):4672-81. Available from: https://bioscmed.com/index.php/bsm/article/view/1041

Most read articles by the same author(s)

1 2 > >>